Therapeutic Advances in Cardiovascular Disease
Subject Categories
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 13 |
| Total Docs. (3 years) | 57 |
| Total Refs. | 306 |
| Total Citations (3 years) | 171 |
| Citable Docs. (3 years) | 55 |
| Citations / Doc. (2 years) | 3.39 |
| Ref. / Doc. | 23.54 |
| % Female | 25.9% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Therapeutic Advances in Cardiovascular Disease?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Therapeutic Advances in Cardiovascular Disease has an SJR of 0.862 and is ranked Q2.
What is the SJR and quartile of Therapeutic Advances in Cardiovascular Disease?
Therapeutic Advances in Cardiovascular Disease has an SJR (SCImago Journal Rank) of 0.862 and its best quartile is Q2.
What is the H-index of Therapeutic Advances in Cardiovascular Disease?
The H-index of Therapeutic Advances in Cardiovascular Disease is 44, meaning 44 of its articles have each been cited at least 44 times.
Is Therapeutic Advances in Cardiovascular Disease indexed in Scopus?
Yes. Therapeutic Advances in Cardiovascular Disease is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.